CureVac (CDMO Services)
Tubingen, DE
Hybrid — also manufactures internal programs
4 confirmed programs
· 1 sponsors
· Last scored 2026-04-29
75.3
Signal Score
○ FDA Inspections
✓ Clinical Trials (4)
○ SEC Filings
○ Press
✓ EMA GMP (7)
○ MHRA GMP
Quick Facts: CureVac (CDMO Services)
- Signal Score
- 75.3/100 (as of 2026-04-29)
- Quality Compliance
- 100.0/100 — No FDA inspection records found for this manufacturer
- Headquarters
- Tubingen, DE
- Modalities
- mRNA
- Active Programs
- 4 confirmed from ClinicalTrials.gov across 1 sponsors
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About CureVac (CDMO Services)
mRNA pioneer with CDMO capabilities.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates7 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
52.5
4 active programs across 1 sponsors
Modalities: mRNA
1 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov
4 active programs across 1 sponsors · Modalities: mRNA · 1 programs in advanced phases (Phase 2/3)
Programs
4
Sponsors1
ModalitiesmRNA
4 active programs across 1 sponsors
Modalities: mRNA
1 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
NCT00923312
Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV...
PHASE1/PHASE2
Completed
Source: ClinicalTrials.gov · Retrieved Jul 04, 2026
Financial Stability
83.0
Publicly traded — financial transparency
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Publicly traded — financial transparency
Capacity
53.0
1 manufacturing site: Tubingen, Germany
Modalities: mRNA
Capacity assessment: 53.0/100
Sites: Tubingen, Germany
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Tubingen, Germany
Modalities: mRNA
Capacity assessment: 53.0/100
CureVac (CDMO Services) EMA GMP Compliance 7 certificates
2025-11
2025-11
2025-11
2024-12
2023-09
2023-09
2023-05
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_BW_01_GMP_2026_0102 | CureVac Manufacturing GmbH | Germany | 2025-11-13 | COMPLIANT |
| DE_BW_01_GMP_2026_0103 | CureVac Manufacturing GmbH | Germany | 2025-11-13 | COMPLIANT |
| DE_BW_01_GMP_2026_0101 | CureVac Manufacturing GmbH | Germany | 2025-11-13 | COMPLIANT |
| DE_BW_01_GMP_2025_0094 | CureVac Manufacturing GmbH | Germany | 2024-12-17 | COMPLIANT |
| DE_BW_01_GMP_2024_0013 | CureVac Manufacturing GmbH | Germany | 2023-09-28 | COMPLIANT |
| DE_BW_01_GMP_2024_0012 | CureVac Manufacturing GmbH | Germany | 2023-09-28 | COMPLIANT |
| DE_BW_01_GMP_2023_0203 | CureVac RNA Printer GmbH | Germany | 2023-05-23 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Jul 04, 2026
Clinical Activity 4 studies
NCT07073183
Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With...
PHASE1
Withdrawn
NCT03291002
Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC
PHASE1
Unknown
NCT01915524
Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV...
PHASE1
Terminated
NCT00923312
Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell...
PHASE1/PHASE2
Completed
Source: ClinicalTrials.gov · Retrieved Jul 04, 2026
Frequently Asked Questions About CureVac (CDMO Services)
Does CureVac (CDMO Services) hold EMA or MHRA GMP certificates?
CDMO Signal tracks 7 EMA GMP certificates for CureVac (CDMO Services).
How many clinical programs is CureVac (CDMO Services) linked to?
CureVac (CDMO Services) is associated with 4 clinical trials in CDMO Signal's ClinicalTrials.gov-sourced data.
What is CureVac (CDMO Services)'s CDMO Signal Score?
CureVac (CDMO Services) has a Signal Score of 75/100, based on quality, operations, financial stability, and capacity data.
Evaluating CureVac (CDMO Services) for a manufacturing program?
Use the free AI matchmaker to compare CureVac (CDMO Services) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
BioNTech (Mfg Services)
Mainz, DE · Marburg, DE
Signal Score: 84.8
mRNA
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 82.5
mRNA, Oligonucleotide, Biologics
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy
Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
Signal Score: 81.6
Recombinant Protein, Plasmid DNA, mRNA
Ethris
Planegg, DE
Signal Score: 56.5
mRNA